CL
Christine Lacabaratz

Publications (3)

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
Article scientifique · 2022
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
Article scientifique · 2021
Long-lasting severe immune dysfunction in Ebola virus disease survivors
Article scientifique · 2019

Domaines principaux

Sciences de la santé3

Statistiques

Consultations12
Téléchargements0